Target intelligence / Profile preview

Myosin heavy chain 14 (MYH14) (MYH14)

Target
MYH14
Molecular classification
Motor protein, Actin-based molecular motor, Non-muscle myosin, Myosin superfamily member
01

Overview

Myosin heavy chain 14 (MYH14) encodes a conventional non-muscle myosin protein, specifically the heavy chain of non-muscle myosin IIC.[2][3] As an actin-dependent motor protein, MYH14 functions as a molecular motor that hydrolyzes ATP and generates physical force to regulate diverse cellular processes including cytokinesis, cell motility, cell polarity, and specialized functions such as secretion and receptor capping.[2][5] The protein assembles into bipolar filaments and interacts with actin to produce contractile force essential for cellular architecture and function.[3] MYH14 is particularly critical in auditory cells, where it maintains inner ear cell structure and hearing function.[3] Mutations in the MYH14 gene result in autosomal dominant hearing impairment and have been associated with other clinical phenotypes including peripheral neuropathy, myopathy, and hoarseness.[2] Unlike some myosin family members, MYH14 is not currently recognized as an established therapeutic target for drug development, and no pharmacological agents are known to specifically modulate its activity.

Other names
Myosin-14Non-muscle myosin IICCellular myosin
02

Mechanism of action

Not applicable — no drugs currently target this protein

03

Biological functions

Cytokinesis (cell division)Cell shape regulationCell motilityCell polarity establishmentSecretionReceptor cappingAuditory cell architecture and functionCytoskeleton organization and remodeling
04

Disease associations

Autosomal dominant hearing impairmentDeafness, autosomal dominant 4APeripheral neuropathyMyopathyHoarseness
05

Safety considerations

Not applicable as a therapeutic target; however, mutations in MYH14 cause hearing loss and related neurological complications

Beyond the preview

Go deeper on Myosin heavy chain 14 (MYH14) (MYH14).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myosin heavy chain 14 (MYH14) (MYH14).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call